https://charts.traderzeitung.de/phases/US75989R1077
string(1409) "{"isin":"US75989R1077","name":"RenovoRx Inc","stock_id_xnas":22560756,"stock_id_xnys":null,"generated_at":"2026-09-24 01:31:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":1.685,"close_at":"2026-09-21 14:51:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":1.68,"close_at":"2026-09-21 21:59:00","complete":true,"perf_pct":-0.2967},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":1.71,"close_at":"2026-09-22 21:59:00","complete":true,"perf_pct":1.7857},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":1.63,"close_at":"2026-09-23 21:59:00","complete":true,"perf_pct":-4.6784},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"
RenovoRx
Trading-Room

RenovoRx Aktie News & Nachrichten

[WKN: A3CYE8 | Symbol: RNXT]
Realtimekurs
   
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Es konnten keine Nachrichten über RenovoRx gefunden werden.